Last reviewed · How we verify
Two-arm Phase III Trial Comparing Different Time of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer
The therapy of photofrin PDT was effective in improving life quality of patients with advanced esophageal and/or gastric cardiac cancer and the time optimizing for employing laser irradiation was of great importance.The purpose of this study is to evaluate the clinical efficacy and adverse effects of Photodynamic Therapy (PDT) on esophageal and/or gastric cardiac cancer during different time after inject photofrin.
Details
| Lead sponsor | The First Affiliated Hospital of Henan University of Science and Technology |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 40 |
| Start date | 2015-10 |
| Completion | 2019-12 |
Conditions
- Stage I Esophageal Adenocarcinoma
- Stage II Esophageal Adenocarcinoma
- Stage III Esophageal Adenocarcinoma
- Stage I Esophageal Squamous Cell Carcinoma
- Stage II Esophageal Squamous Cell Carcinoma
- Stage III Esophageal Squamous Cell Carcinoma
Interventions
- photosensitizer(photofrin)
- 630 nm laser irradiation (DIOMED)
Primary outcomes
- Partial remission rate — 3 months
Photodynamic therapy for 3 months after the review of gastroscope for pathologic examination, to check the response rate
Countries
China